ID
17536
Beschrijving
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.; ODM derived from: https://clinicaltrials.gov/show/NCT00087594
Link
https://clinicaltrials.gov/show/NCT00087594
Trefwoorden
Versies (1)
- 22-09-16 22-09-16 -
Geüploaded op
22 september 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C, Chronic NCT00087594
Eligibility Hepatitis C, Chronic NCT00087594
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Prior Therapy Hepatitis C, Chronic
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0524910
Beschrijving
HIV coinfection
Datatype
boolean
Alias
- UMLS CUI [1]
- C4062778
Beschrijving
Illicit drug use Intravenous | Illicit drug use
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0281875
- UMLS CUI [1,2]
- C1522726
- UMLS CUI [2]
- C0281875
Beschrijving
Decompensated cirrhosis
Datatype
boolean
Alias
- UMLS CUI [1]
- C1619727
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Hepatitis C, Chronic NCT00087594
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C1148363 (UMLS CUI [2])
C0524910 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C0524910 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C0281875 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Geen commentaren